Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adrian Thrasher

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Plos One|February 4, 2014
Frozen cord blood hematopoietic stem cells differentiate into higher numbers of functional natural killer cells in vitro than mobilized hematopoietic stem cells or freshly isolated cord blood hematopoietic stem cellsMartha Luevano, Anna Domogala, Michael Blundell, et al.
Plos One|November 9, 2013
Production and first-in-man use of T cells engineered to express a HSVTK-CD34 sort-suicide geneHong Zhan, Kimberly Gilmour, Lucas Chan, et al.
Plos One|October 15, 2015
Natural Killer Cells Improve Hematopoietic Stem Cell Engraftment by Increasing Stem Cell Clonogenicity In Vitro and in a Humanized Mouse ModelMichelle Escobedo-Cousin, Nicola Jackson, Raquel Laza-Briviesca, et al.
Stem Cells (Dayton, Ohio)|February 28, 2012
A small molecule modulator of prion protein increases human mesenchymal stem cell lifespan, ex vivo expansion, and engraftment to bone marrow in NOD/SCID miceSindhu T Mohanty, Claire J Cairney, Andrew D Chantry, et al.
Plos One|June 28, 2007
Real-time definition of non-randomness in the distribution of genomic eventsUlrich Abel, Annette Deichmann, Cynthia Bartholomae, et al.
Molecular Therapy. Methods & Clinical Development|July 1, 2024
Design and validation of a GMP stem cell manufacturing protocol for MPSII hematopoietic stem cell gene therapyStuart Ellison, Karen Buckland, Yuko Learmonth, et al.
Human Gene Therapy. Clinical Development|December 17, 2013
Phase I study protocol for ex vivo lentiviral gene therapy for the inherited skin disease, Netherton syndromeWei-Li Di, Jemima E Mellerio, Catina Bernadis, et al.
Human Gene Therapy|April 11, 2015
Adoptive T-cell therapy for cancer in the United kingdom: a review of activity for the British Society of Gene and Cell Therapy annual meeting 2015David Edward Gilham, John Anderson, John Stephen Bridgeman, et al.
Journal of Translational Medicine|October 12, 2018
Tailoring cells for clinical needs: Meeting report from the Advanced Therapy in Healthcare symposium (October 28-29 2017, Doha, Qatar)Sara Deola, Bella S Guerrouahen, Heba Sidahmed, et al.
The Journal of Allergy and Clinical Immunology|May 16, 2017
Treatment of severe forms of LPS-responsive beige-like anchor protein deficiency with allogeneic hematopoietic stem cell transplantationMarkus G Seidel, Katrin Böhm, Figen Dogu, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Plos One|February 4, 2014
Frozen cord blood hematopoietic stem cells differentiate into higher numbers of functional natural killer cells in vitro than mobilized hematopoietic stem cells or freshly isolated cord blood hematopoietic stem cellsMartha Luevano, Anna Domogala, Michael Blundell, et al.
Plos One|November 9, 2013
Production and first-in-man use of T cells engineered to express a HSVTK-CD34 sort-suicide geneHong Zhan, Kimberly Gilmour, Lucas Chan, et al.
Plos One|October 15, 2015
Natural Killer Cells Improve Hematopoietic Stem Cell Engraftment by Increasing Stem Cell Clonogenicity In Vitro and in a Humanized Mouse ModelMichelle Escobedo-Cousin, Nicola Jackson, Raquel Laza-Briviesca, et al.
Stem Cells (Dayton, Ohio)|February 28, 2012
A small molecule modulator of prion protein increases human mesenchymal stem cell lifespan, ex vivo expansion, and engraftment to bone marrow in NOD/SCID miceSindhu T Mohanty, Claire J Cairney, Andrew D Chantry, et al.
Plos One|June 28, 2007
Real-time definition of non-randomness in the distribution of genomic eventsUlrich Abel, Annette Deichmann, Cynthia Bartholomae, et al.
Molecular Therapy. Methods & Clinical Development|July 1, 2024
Design and validation of a GMP stem cell manufacturing protocol for MPSII hematopoietic stem cell gene therapyStuart Ellison, Karen Buckland, Yuko Learmonth, et al.
Human Gene Therapy. Clinical Development|December 17, 2013
Phase I study protocol for ex vivo lentiviral gene therapy for the inherited skin disease, Netherton syndromeWei-Li Di, Jemima E Mellerio, Catina Bernadis, et al.
Human Gene Therapy|April 11, 2015
Adoptive T-cell therapy for cancer in the United kingdom: a review of activity for the British Society of Gene and Cell Therapy annual meeting 2015David Edward Gilham, John Anderson, John Stephen Bridgeman, et al.
Journal of Translational Medicine|October 12, 2018
Tailoring cells for clinical needs: Meeting report from the Advanced Therapy in Healthcare symposium (October 28-29 2017, Doha, Qatar)Sara Deola, Bella S Guerrouahen, Heba Sidahmed, et al.
The Journal of Allergy and Clinical Immunology|May 16, 2017
Treatment of severe forms of LPS-responsive beige-like anchor protein deficiency with allogeneic hematopoietic stem cell transplantationMarkus G Seidel, Katrin Böhm, Figen Dogu, et al.
Pageof 4